Articles from GlobeNewswire

NEW YORK and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced the pricing of a registered underwritten offering of 26,190,477 common shares, at a price of $2.10 per share. atai has granted the underwriter a 30-day option to purchase up to an additional 3,928,571 common shares. All common shares to be sold in the offering will be sold by atai.
By atai Life Sciences · Via GlobeNewswire · February 12, 2025

SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced the pricing of its initial public offering of 5,888,000 shares of its common stock at a public offering price of $16.00 per share. All of the shares are being offered by Aardvark. The gross proceeds to Aardvark from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $94.2 million. Aardvark’s common stock is expected to begin trading on the Nasdaq Global Select Market on February 13, 2025 under the ticker symbol “AARD.” The offering is expected to close on February 14, 2025, subject to the satisfaction of customary closing conditions. In addition, Aardvark has granted the underwriters a 30-day option to purchase up to an additional 883,200 shares of common stock at the public offering price, less underwriting discounts and commissions.
By Aardvark Therapeutics, Inc. · Via GlobeNewswire · February 12, 2025

Press Release
By Nokia Oyj · Via GlobeNewswire · February 12, 2025

By USDA Food Safety and Inspection Service · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Elastic N.V. (“Elastic” or the “Company”) (NYSEESTC) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Elastic securities between May 31, 2024 and August 29, 2024, both dates inclusive (the “Class Period”). Investors have until April 14, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Skyworks Solutions, Inc. (“Skyworks” or the “Company”) (NASDAQSWKS) on behalf of Skyworks stockholders. Our investigation concerns whether Skyworks has violated the federal securities laws and/or engaged in other unlawful business practices.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2025

By Sonoco Products Company · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Semtech Corporation (“Semtech” or the “Company”) (NASDAQSMTC) on behalf of Semtech stockholders. Our investigation concerns whether Semtech has violated the federal securities laws and/or engaged in other unlawful business practices.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edison International (“Edison” or the “Company”) (NYSEEIX) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edison securities between February 25, 2021 and February 6, 2025, both dates inclusive (the “Class Period”). Investors have until April 14, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against ICON Public Limited Company (“ICON” or the “Company”) (NASDAQICLR) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired ICON securities between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”). Investors have until April 11, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2025

HARTSVILLE, S.C., Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Sonoco (NYSESON) has declared a $0.52 per share quarterly common stock dividend. This dividend will be paid on March 10, 2025, to shareholders of record as of February 26, 2025.
By Sonoco Products Company · Via GlobeNewswire · February 12, 2025

VANCOUVER, British Columbia, Feb. 12, 2025 (GLOBE NEWSWIRE) -- GoldQuest Mining Corp. (TSXV:GQC), “GoldQuest” or the “Company”) announces that the board of directors of the Company has authorized the grant of an aggregate of 6,400,000 incentive stock options (the “Options”) to existing directors, officers and certain employees of the Company, at an exercise price of $0.31 per common share.
By GoldQuest Mining Corp. · Via GlobeNewswire · February 12, 2025

A Comprehensive, Evidence-Based Review of GLP-1/GIP Agonists for Fitness and Wellness Professionals
By The National Academy of Sports Medicine · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP is investigating whether Kestra Financial and Cetera Financial Group violated the law and their duties to act in the best interest of their clients by paying unreasonably low rates of interest on their account holders’ uninvested cash.
By DiCello Levitt LLP · Via GlobeNewswire · February 12, 2025

CALGARY, Alberta, Feb. 12, 2025 (GLOBE NEWSWIRE) -- This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For a full disclosure of the forward-looking information and statements and the risks to which they are subject, see the “Cautionary Statement Regarding Forward-Looking Information and Statements” later in this news release. This news release contains references to certain Financial Measures and Ratios, including Adjusted EBITDA (earnings before income taxes, gain on acquisition, loss on investments and other assets, gain on repurchase of unsecured senior notes, finance charges, foreign exchange, loss on asset decommissioning, gain on asset disposals and depreciation and amortization), Funds Provided by (Used in) Operations, Net Capital Spending, Working Capital and Total Long-term Financial Liabilities. These terms do not have standardized meanings prescribed under International Financial Reporting Standards (IFRS) and may not be comparable to similar measures used by other companies. See “Financial Measures and Ratios” later in this news release.
By Precision Drilling Corporation · Via GlobeNewswire · February 12, 2025

CLEVELAND, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSEPH), the global leader in motion and control technologies, today announced that it is scheduled to present at the Barclays Industrial Select Conference in Miami Beach, Florida on February 19, 2025 at 11:00 a.m. Eastern time. A live webcast of the presentation will be accessible on Parker's investor information website at investors.parker.com and will be archived on the site.
By Parker-Hannifin Corporation · Via GlobeNewswire · February 12, 2025

CHICAGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed in Lake County Circuit Court, Nineteenth Judicial Circuit, State of Illinois, on behalf of all persons and entities who acquired Assertio Holdings, Inc. (NASDAQASRT) (“Assertio” or the “Company”) common stock issued in exchange for Spectrum Pharmaceuticals, Inc. (“Spectrum”) common stock in connection with Assertio’s July 31, 2023 merger with Spectrum (the “Merger”), charging the Company and certain of its current and former senior executives and directors with violations of the federal securities laws (collectively, “Defendants”).
By DiCello Levitt LLP · Via GlobeNewswire · February 12, 2025

SAN CARLOS, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQIOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on February 10, 2025 (the “Date of Grant”), the Company approved the grant of inducement stock options and restricted stock units covering an aggregate of up to 305,000 shares of Iovance’s common stock to Daniel Kirby, the Company’s new Chief Commercial Officer.
By Iovance Biotherapeutics, Inc. · Via GlobeNewswire · February 12, 2025

SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQTVTX) today announced that on February 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 115,100 shares of its common stock to ten new employees, consisting of inducement stock options to purchase an aggregate of 36,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 79,100 shares of its common stock. These inducement stock options and inducement RSUs are subject to the terms of Travere’s 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4).
By Travere Therapeutics, Inc. · Via GlobeNewswire · February 12, 2025

WINTER PARK, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Pursuant to the Investment Management Trust Agreement between Integrated Rail and Resources Acquisition Corp. (the “Company”) and American Stock Transfer & Trust Company, LLC, dated as of November 11, 2021, as amended on February 8, 2024, the Company received notice from the Company’s sponsor, DHIP Natural Resources Investments, LLC, that the Company intends to extend the time available in order to consummate a business combination from February 15, 2025 to March 15, 2025.
By Integrated Rail and Resources Acquisition Corp. · Via GlobeNewswire · February 12, 2025

SPOKANE, Wash., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Avista Corp.’s (NYSEAVA) board of directors has declared a quarterly dividend of $0.49 per share on the company’s common stock, an increase of $0.015 per share, yielding an annualized dividend of $1.96. The common stock dividend is payable March 14, 2025, to shareholders of record at the close of business on February 26, 2025.
By Avista Corporation · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Newmont Corporation (NYSENEM) between February 22, 2024 and October 23, 2024, inclusive (the “Class Period”), of the important April 1, 2025 lead plaintiff deadline.
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Paladin Energy Ltd (OTC: PALAF) resulting from allegations that Paladin may have issued materially misleading business information to the investing public.
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2025

Mike Lindell Media Corp. (formerly FrankSpeech Network) Welcomes Nikki Stanzione, a Seasoned Broadcaster Who Extensively Covered the 2024 Presidential Election Campaign for Right Side Broadcasting Network (RSBN).
By FrankSpeech Broadcast Network · Via GlobeNewswire · February 12, 2025

All dollar amounts are expressed in Canadian currency
By D-BOX Technologies Inc. · Via GlobeNewswire · February 12, 2025

Delivered on all key guidance metricsAchieved record free cash flow of more than $1.3 billion and repaid $800 million of debtStrong three-year outlook of 2.0 million Au eq. oz. per year
By Kinross Gold Corporation · Via GlobeNewswire · February 12, 2025

TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (TSX: K; NYSE: KGC) (the “Company”) today announced that the Company’s Board of Directors has declared a dividend of US$0.03 per common share for the fourth quarter of 2024.
By Kinross Gold Corporation · Via GlobeNewswire · February 12, 2025

Achieves equivalent rated power in a smaller size with guaranteed stable long-term supply
By ROHM Semiconductor · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Brookfield Public Securities Group LLC (“PSG”) today announced upcoming changes to the Brookfield Real Assets Income Fund Inc. (“RA” or the “Fund”) portfolio management team.
By Brookfield Real Assets Income Fund Inc. · Via GlobeNewswire · February 12, 2025

MELBOURNE, Australia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the Marketing Authorization Application (MAA) for its prostate cancer PET1 imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection).
By Telix Pharmaceuticals Limited · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2025

Bahamian rocket scientist’s work vital to success of landing
By The Bahamas Ministry of Tourism · Via GlobeNewswire · February 12, 2025

GREENWICH, Conn., Feb. 12, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSEGXO) today announced results for the fourth quarter and full year 2024.
By GXO Logistics · Via GlobeNewswire · February 12, 2025

ARCHBOLD, Ohio, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today reported financial results for the 2024 fourth quarter and twelve months ended December 31, 2024.
By Farmers & Merchants Bancorp, Inc. · Via GlobeNewswire · February 12, 2025

Shelton, CT, Feb. 12, 2025 (GLOBE NEWSWIRE) --
By Hubbell Inc. · Via GlobeNewswire · February 12, 2025

GREELEY, Colo., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Pilgrim’s Pride Corporation (NASDAQPPC), one of the world's leading food companies, reports its fourth quarter and year-end 2024 financial results.
By Pilgrim's Pride Corporation · Via GlobeNewswire · February 12, 2025

MOUNT LAUREL, N.J., Feb. 12, 2025 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (NASDAQJJSF) announced today that its Board of Directors has declared a quarterly cash dividend of $0.78 per share of its common stock payable on April 8, 2025, to shareholders of record as of the close of business on March 18, 2025.
By J & J Snack Foods Corp. · Via GlobeNewswire · February 12, 2025

DAVIDSON, N.C., Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Ingersoll Rand Inc. (NYSEIR), a global provider of mission-critical flow creation and life science and industrial solutions, declared today a regular quarterly cash dividend of $0.02 (two cents) per share of common stock payable on March 27, 2025 to stockholders of record on March 5, 2025.
By Ingersoll Rand · Via GlobeNewswire · February 12, 2025

VANCOUVER, British Columbia and SAN FRANCISCO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in two upcoming investor conferences in March 2025:
By Jade Biosciences · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2025

Minneapolis, MN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQSEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, will release its fourth quarter 2024 results after the market close on February 25, 2025. The Company will host a conference call at 5:00pm ET that same day.
By Sezzle · Via GlobeNewswire · February 12, 2025

Delivers full year Sales growth of 7%, GAAP EPS of $3.19 and Adjusted EPS of $4.26
By Crane NXT · Via GlobeNewswire · February 12, 2025

GREENWICH, Conn., Feb. 12, 2025 (GLOBE NEWSWIRE) -- QXO, Inc. (NYSEQXO) announced today that it has informed Beacon Roofing Supply, Inc. (Nasdaq: BECN) that it will propose 10 independent director nominees at Beacon’s 2025 Annual Meeting of Shareholders to replace Beacon’s Board of Directors.
By QXO, Inc. · Via GlobeNewswire · February 12, 2025

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
By Nanobiotix S.A. · Via GlobeNewswire · February 12, 2025

ETF platform strongly outperforms AUM and volume targets for MDSTWestwood Engineered Beta partnership launches first two innovative ETFsWestwood’s Board authorized an additional $5.0 million of share repurchases
By Westwood Holdings Group Inc · Via GlobeNewswire · February 12, 2025

Land Management and Other Operations Revenue Increased 45% Compared to Prior Year
By Alico, Inc. · Via GlobeNewswire · February 12, 2025

NEWARK, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQCNXC), a global technology and services leader, today announced the release of iX Hello 2.0.
By Concentrix Solutions Corporation · Via GlobeNewswire · February 12, 2025

Record Revenue, $53.7m Operating Cashflow, $18.9m NPAT
By IREN · Via GlobeNewswire · February 12, 2025

Achieves record revenue, GAAP net income1 and adjusted EBITDA2,3 for the fourth quarter and full year 2024Fourth-quarter revenue of $191.5 million and GAAP net income1 of $147.2 millionFourth-quarter adjusted EBITDA2,3 of $50.2 million or 26% adjusted EBITDA margin, Upwork’s highest ever Full-year revenue of $769.3 million, GAAP net income1 of $215.6 million, and adjusted EBITDA2,3 of $167.6 million
By Upwork Inc. · Via GlobeNewswire · February 12, 2025

RICHMOND, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (the “Company”) a Fortune 500 company and one of the largest convenience store operators in the United States, today announced that the Company will host a conference call on Wednesday, February 26, 2025 at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2024.
By ARKO CORP. · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQODD), today announced that it will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, February 25, 2025, to be followed by a conference call on Wednesday, February 26, 2025, at 8:30 a.m. Eastern Time.
By Oddity Tech Ltd. · Via GlobeNewswire · February 12, 2025

EDINBURG, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (Shentel) (NASDAQSHEN) will release its fourth quarter and full year 2024 financial results before the market opens on Thursday, February 20, 2025, and will host a conference call and simultaneous webcast on the same day at 8:30 a.m. Eastern Time to discuss Shentel’s financial results and business highlights.
By Shenandoah Telecommunications Co · Via GlobeNewswire · February 12, 2025

CINCINNATI, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced that its Board of Directors declared monthly dividend distributions of $0.1025 per share of the Company’s common stock payable on April 1, 2025 and May 1, 2025 to stockholders of record as of March 17, 2025 and April 15, 2025, respectively.
By Phillips Edison & Company, Inc. · Via GlobeNewswire · February 12, 2025

BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (Nasdaq: RPD), a leader in extended risk and threat detection, today announced its financial results for the fourth quarter and full-year 2024.
By Rapid7 · Via GlobeNewswire · February 12, 2025

Fourth Quarter 2024 Highlights:
By Veeco Instruments Inc. · Via GlobeNewswire · February 12, 2025

EL SEGUNDO, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQBYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the fourth quarter and full year ended December 31, 2024 on Wednesday, February 26, 2025 after market close.
By Beyond Meat, Inc. · Via GlobeNewswire · February 12, 2025

SAN ANTONIO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQGROW) (the “Company”), a registered investment advisory firm1 with longstanding experience in global markets and specialized sectors, today reported operating revenues of $2.2 million, with a net loss of $86,000, or a loss of $0.01 per share, for the quarter ended December 31, 2024.
By U.S. Global Investors · Via GlobeNewswire · February 12, 2025

SAN CARLOS, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today that it will report financial results for the fourth quarter and full year 2024 after market close on February 25, 2025. Company management will host a conference call and webcast beginning at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a business update.
By Vaxcyte, Inc. · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Intellia Therapeutics, Inc. (“Intellia” or the “Company”) (NASDAQNTLA) between July 30, 2024 and January 8, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · February 12, 2025

Q4 Revenues up 115% year-over-year to a record $1.01 billion.Q4 Net Deposits grow to a record $16 billion.Q4 Gold Subscribers up 86% year-over-year to a record 2.6 million.Q4 Net Income up over 10X year-over-year to a record $916 million, or Diluted EPS of a record $1.01.Q4 Adjusted EBITDA up over 300% year-over-year to a record $613 million.
By Robinhood Markets, Inc. · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Edison International (“Edison” or the “Company”) (NYSEEIX) between February 25, 2021 and February 6, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · February 12, 2025

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company”), a global leader in AI at the convergence of insurance and mobility, today announced its financial results for the three and nine-month periods ended December 31, 2024.
By Roadzen Inc. · Via GlobeNewswire · February 12, 2025

PALM BEACH GARDENS, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the fourth quarter and full-year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
By ZimVie Inc. · Via GlobeNewswire · February 12, 2025

Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and Orphan Drug Designation
By Rezolute, Inc. · Via GlobeNewswire · February 12, 2025

BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its fourth quarter and full year 2024 financial results will be released after market close on Tuesday, February 25, 2025. Flywire will host a conference call to discuss its fourth quarter and full year 2024 financial results at 5:00pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, and Cosmin Pitigoi, CFO.
By Flywire Corporation · Via GlobeNewswire · February 12, 2025

BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSEAMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report.
By Amwell · Via GlobeNewswire · February 12, 2025

VANCOUVER, Wash., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQBBSI), a leading provider of business management solutions, will conduct a conference call on Wednesday, February 26, 2025, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to discuss its financial results for the fourth quarter and full year ended December 31, 2024. The company will report its financial results in a press release prior to the conference call.
By Barrett Business Services Inc · Via GlobeNewswire · February 12, 2025

DALLAS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (NASDAQBRY) (“Berry” or the “Company”) today announced it will report fourth quarter and full year 2024 results on Wednesday, March 12, 2025, after the close of U.S. financial markets and will host a conference call and webcast Thursday morning, March 13, 2025, to discuss these results; details and links are provided below.
By Berry Corporation (Bry) · Via GlobeNewswire · February 12, 2025

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein
By Galapagos NV · Via GlobeNewswire · February 12, 2025

NEW YORK and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced the commencement of a proposed registered underwritten offering of $55,000,000 of its common shares. atai expects to grant the underwriter a 30-day option to purchase up to an additional $8,250,000 of common shares. All common shares to be sold in the offering will be sold by atai.
By atai Life Sciences · Via GlobeNewswire · February 12, 2025

JACKSONVILLE, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQCSX) announced that the Company’s Board of Directors approved an eight percent increase in its quarterly dividend, from $0.12 to $0.13 per share. The new $0.13 quarterly dividend is payable on March 14, 2025, to shareholders of record at the close of business on February 28, 2025.
By CSX Corporation · Via GlobeNewswire · February 12, 2025

~Revised FY2024 revenue guidance is $26.3M instead of previous guidance of $24M
By ConnectM Technology Solutions, Inc. · Via GlobeNewswire · February 12, 2025

Study Progresses to Fourth Higher 90 mg/m2 Dose Cohort
By Bio-Path Holdings, Inc. · Via GlobeNewswire · February 12, 2025

Company to Host Conference Call with Live Q&A, February 26, 2025, at 4:30pm ET / 22:30 CET
By mdxhealth · Via GlobeNewswire · February 12, 2025

Strategic IR Partnership to Enhance Investor Presence Across Key Global Markets
By Diginex Limited · Via GlobeNewswire · February 12, 2025